ImmunoGen, Inc. Annual Income Tax Expense (Benefit) in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
ImmunoGen, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2022.
  • ImmunoGen, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was -$1.17M.
  • ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2022 was $1.22M.
  • ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
  • ImmunoGen, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $1.22M +$1.22M Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $0 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $0 $0 Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $0 Jan 1, 2017 Dec 31, 2017 10-K 2020-03-11
2010 -$265K Jul 1, 2009 Jun 30, 2010 10-K 2012-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.